Skip to Content

B 251 (Phenazopyridine Plus butabarbital 15 mg / hyoscyamine hydrobromide 0.3 mg / phenazopyridine hydrochloride 150 mg)

Pill with imprint B 251 is Brown, Elliptical / Oval and has been identified as Phenazopyridine Plus butabarbital 15 mg / hyoscyamine hydrobromide 0.3 mg / phenazopyridine hydrochloride 150 mg. It is supplied by Breckenridge Pharmaceutical, Inc..

Butabarbital/hyoscyamine/phenazopyridine is used in the treatment of dysuria and belongs to the drug class urinary antispasmodics. There is positive evidence of human fetal risk during pregnancy. Butabarbital/hyoscyamine/phenazopyridine butabarbital 15 mg / hyoscyamine hydrobromide 0.3 mg / phenazopyridine hydrochloride 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for B 251

Phenazopyridine Plus

Imprint:
B 251
Strength:
butabarbital 15 mg / hyoscyamine hydrobromide 0.3 mg / phenazopyridine hydrochloride 150 mg
Color:
Brown
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Urinary antispasmodics
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Breckenridge Pharmaceutical, Inc.
National Drug Code (NDC):
51991-0251

Get help with Imprint Code FAQs.

More about butabarbital/hyoscyamine/phenazopyridine

Professional resources

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide